Temporal indication of cannabis use by means of THC glucuronide determination

Drug Testing and Analysis

Volumn 1, Issue 11-12, 2009, Pages 505-510

  Mareck, Ute ^a   Haenelt, Nadine ^a   Geyer, Hans ^a   Guddat, Sven ^a   Kamber, Matthias ^b   Brenneisen, Rudolf ^c   Thevis, Mario ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b Antidoping Schweiz   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cannabis; Doping; Liquid chromatographymass spectrometry; Sport; Urine

Indexed keywords

BODY FLUIDS; EXTRACTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY;

ACCURATE PREDICTION; CANNABINOIDS; CANNABIS; DOPING CONTROL; GLUCURONIDES; HALF LIVES; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; URINE; URINE SAMPLE; WORLD ANTI-DOPING AGENCY;

MASS SPECTROMETRY;

GLUCURONIDE; TETRAHYDROCANNABINOLIC ACID;

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; CANNABIS ADDICTION; CIGARETTE SMOKING; CLINICAL INDICATOR; COMPETITION; DOPING; DRUG SCREENING; FEMALE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 77953470306     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.106     Document Type: Article

References (39)

1. M. A. Huestis, E. J. Cone, J. Anal. Toxicol. 1998, 22, 445.
2. A. D. Fraser, D. Worth, J. Anal. Toxicol. 1999, 23, 531.
3. A. D. Fraser, D. Worth, Forensic Sci. Int. 2003, 133, 26.
4. A. D. Fraser, D. Worth, Forensic Sci. Int. 2003, 137, 196.
5. A. D. Fraser, D. Worth, Forensic Sci. Int. 2004, 143, 147.
6. J. E. Manno, B. R. Manno, P.M. Kemp, D. D. Alford, I. K. Abukhalaf, M. E. McWilliams, F. N. Hagaman, M. J. Fitzgerald, J. Anal. Toxicol. 2001, 25, 538.
7. G. Skopp, L. Pötsch, B. Ganßmann, M. Mauden, B. Richter, R. Aderjan, R. Mattern, Rechtsmedizin 1999, 10, 21.
8. R. H. Lowe, T. T. Abraham, W. D. Darwin, R. Herning, J. L. Cadet,M. A. Huestis, Drug Alcohol Depend. 2009, 105, 24.
9. G. Skopp, L. Potsch, Clin. Chem. 2002, 48, 301.
10. G. Skopp, L. Pötsch, J. Anal. Toxicol. 2004, 28, 35.
11. M. A. Huestis, E. J. Cone, J. Anal. Toxicol. 2004, 28, 394.
12. T. Saito, A. Wtsadik, K. B. Scheidweiler, N. Fortner, S. Takeichi, M. A. Huestis, Clin. Chem. 2004, 50, 2083.
13. M. M. Halldin, M. Widmann, Arzneimittelforschung 1983, 33, 177.
14. E. Johansson, M. M. Halldin, J. Anal. Toxicol. 1989, 13, 218.
15. M. A. Huestis, E. J. Cone, Ther. Drug Monit. 1998, 20, 570.
16. M. A. Huestis, J. M. Mitchell, E. J. Cone, J. Anal. Toxicol. 1996, 20, 441.
17. World Anti-Doping Agency, The 2009 Prohibited List, International Standard, www.wada-ama.org/rtecontent/document/2009-Prohibited- List-ENG-Final-20-Sept-08.pdf, accessed 21 December 2009.
18. M. A. Huestis, J. M. Mitchell, E. J. Cone, J. Anal. Toxicol. 1995, 19, 443.
19. R. A. Gustafson, I. Kim, P. R. Stout, K. L. Klette, M. P. George, E. T. Moolchan, B. Levine, M. A. Huestis, J. Anal. Toxicol. 2004, 28, 160.
20. World Anti-Doping Agency, Overview of results reported by the 31 IOC/WADA-accredited Laboratories, www.dshs-koeln.de/biochemie/rubriken/07-info/ WADA-Statistik-2003.pdf, accessed 21 December 2009.
21. World Anti-Doping Agency, 2004 Adverse Analytical Findings Reported by Accredited Laboratories, www.dshs-koeln.de/biochemie/rubriken/07-info/WADA- Statistik-2004.pdf, accessed 21 December 2009.
22. World Anti-Doping Agency, 2005 Adverse Analytical Findings Reported by Accredited Laboratories, www.dshs-koeln.de/biochemie/rubriken/07-info/WADA- Statistik-2005.pdf, accessed 21 December 2009.
23. World Anti-Doping Agency, 2006 Adverse Analytical Findings Reported by Accredited Laboratories, www.dshs-koeln.de/biochemie/rubriken/07-info/WADA- Statistik-2006.pdf, accessed 21 December 2009.
24. World Anti-Doping Agency, 2007 Adverse Analytical Findings Reported by Accredited Laboratories, www.wada-ama.org/rtecontent/document/LABSTATS-2007.PDF, accessed 21 December 2009.
25. World Anti-Doping Agency, 2008, Adverse Analytical Findings and Atypical FindingsReportedbyAccredited Laboratories, (27.10.2009) www.wada-ama.org/rtecontent/document/LABSTATS-2008.pdf accessed 27 October 2009.
26. B. Maralikova, W. Weinmann, J. Mass Spectrom. 2004, 39, 526.
27. P.M. Kemp, I. K. Abukhalaf, J. E. Manno, B. R. Manno, D. D. Alford, M. E. McWilliams, F. E. Nixon, M. J. Fitzgerald, R. R. Reeves, M. J. Wood, J. Anal. Toxicol. 1995, 19, 292.
28. T. T. Abraham, R. H. Lowe, S. O. Pirnay, W. D. Darwin, M. A. Huestis, J. Anal. Toxicol. 2007, 31, 477.
29. M. A. Huestis, M. Elsohly, W. Nebro, A. Barnes, R. A. Gustafson, M. L. Smith, Ther. Drug Monit. 2006, 28, 540.
30. R. A. Gustafson, E. T. Moolchan, A. Barnes, B. Levine, M. A. Huestis, Journal of Chromatography. B 2003, 198, 145.
31. T. Nadulski, F. Sporkert, M. Schnelle, A. M. Stadelmann, P. Roser, T. Schefter, F. Pragst, J. Anal. Toxicol. 2005, 29, 782.
32. M. A. Huestis, A. Barnes, M. L. Smith, Clin. Chem. 2005, 51, 2289.
33. U. Mareck-Engelke, H. Geyer, W. Schänzer, Recent Advances in Doping Analysis (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke), Sport & Buch Strauß: Cologne, 1999, p 51.
34. S. Kromidas, Validierung in der Analytik, Wiley-VCH: Weinheim,1999.
35. T. M. Annesley, Clin. Chem. 2003, 49, 1041.
36. T. Kuuranne, M. Vahermo, A. Leinonen, R. Kostiainen, Am. Soc. Mass Spectrom. 2000, 11, 722.
37. Validation of Analytical Procedures: Text andMethodology Q2 (R1), www.ich.org/LOB/media/MEDIA417.pdf, accessed 21 December 2009.
38. W. Gottwald, Statistik für Anwender, Wiley-VCH: Weinheim, 2000.
39. M. A. Huestis, Forensic Sci. Rev. 2002, 14, 16.